Log In
Print
BCIQ
Print
Print this Print this
 

Oral FluCide

  Manage Alerts
Collapse Summary General Information
Company NanoViricides Inc.
DescriptionOral version of a nanoviricide designed to bind to the region of hemagglutinin that binds to the native sialic acid receptor
Molecular Target
Mechanism of Action 
Therapeutic ModalityNanotherapy
Latest Stage of DevelopmentPreclinical
Standard IndicationInfluenza virus
Indication DetailsPrevent influenza A (H1N1) virus infection; Treat influenza A (H1N1) virus infection; Treat influenza A (H3N2) virus infection
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today